Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,685 | 6,740 | 10,897 | 13,468 | 16,537 |
| Marketable Securities | N/A | 22 | 1,802 | 2,623 | 4,277 |
| Receivables | 2,609 | 5,363 | 7,600 | 15,345 | 11,143 |
| Inventories | 2,611 | 3,397 | 4,153 | 5,252 | 12,925 |
| TOTAL | $11,915 | $18,162 | $27,164 | $39,576 | $47,152 |
| Non-Current Assets | |||||
| PPE Net | 7,142 | 7,402 | 7,658 | 7,868 | 8,488 |
| Investments And Advances | 1,716 | 1,716 | 1,914 | 1,913 | 2,246 |
| Intangibles | 224 | 230 | 233 | 238 | 1,117 |
| Other Non-Current Assets | 3,465 | 3,692 | 3,852 | 4,079 | 4,613 |
| TOTAL | $12,547 | $13,040 | $13,657 | $14,098 | $16,464 |
| Total Assets | $24,462 | $31,202 | $40,821 | $53,674 | $63,616 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 18,855 | 18,734 | 18,492 | 18,385 | N/A |
| Accounts payable and accrued liabilities | 560 | 805 | 1,195 | 2,723 | 1,764 |
| Accrued Expenses | 20,006 | 18,198 | 14,026 | 15,344 | 12,975 |
| TOTAL | $39,421 | $37,737 | $33,713 | $36,452 | $14,739 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 19,123 |
| Other Non-Current Liabilities | 13,633 | 13,775 | 15,178 | 15,371 | 15,907 |
| TOTAL | $13,633 | $13,775 | $15,178 | $15,371 | $35,030 |
| Total Liabilities | $53,054 | $51,512 | $48,891 | $51,823 | $49,769 |
| Shareholders' Equity | |||||
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -735,090 | -724,200 | -710,825 | -700,075 | -685,705 |
| Other shareholders' equity | -4,742 | -1,844 | -1,832 | -1,378 | -3,047 |
| TOTAL | $-28,592 | $-20,310 | $-8,070 | $1,851 | $13,847 |
| Total Liabilities And Equity | $24,462 | $31,202 | $40,821 | $53,674 | $63,616 |